Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Concurrent activation of regenerative and tolerogenic processes by fibroblast-based compositions for the treatment of multiple sclerosis

Concurrent activation of regenerative and tolerogenic processes by fibroblast-based compositions for the treatment of multiple sclerosis

US Patent 11878037 · Granted Jan 23, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of cerebral palsy using fibroblasts2025
Treatment of cerebral palsy using fibroblasts2025
Adipose cells for chondrocyte applications2025
Prevention of recurrent miscarriages through administration of fibroblasts and f2025
Prevention of recurrent miscarriages through administration of fibroblasts and f2025
Prevention and/or treatment of type 1 diabetes by augmentation of myeloid suppre2025
Treatment of heart failure and/or post infarct pathological remodeling by ex viv2025
Stimulation of angiogenesis by fibroblast derived exosomes2025
Stimulation of angiogenesis by fibroblast derived exosomes2025
Interaction of fibroblasts and immune cells for activation and uses thereof2025
Interaction of fibroblasts and immune cells for activation and uses thereof2025
Treatment of opioid addiction using fibroblasts and products thereof2024